Status:
COMPLETED
Potential Use of Indocyanine Green as a Fluorescent Agent for Definition of Surgical Margins in Cancer
Lead Sponsor:
Emory University
Conditions:
Malignant Neoplasm
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The surgeon may remove a very small amount of additional tissue compared to what would be removed if you were not enrolled in the study. This tissue may prove to contain tumor or it may contain normal...
Detailed Description
PRIMARY OBJECTIVES: I. To validate the use of intraoperative indocyanine green (ICG) for better definition of tumor margins therefore, minimizing the necessity of a second surgical procedure to obtai...
Eligibility Criteria
Inclusion
- Patients with a tumor that will be treated surgically.
Exclusion
- Patients with a known history of reaction to iodine or iodine-containing compounds.
- Pregnant women. Any patients found to be pregnant will be excluded from the study.
Key Trial Info
Start Date :
June 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01884584
Start Date
June 1 2012
End Date
January 1 2015
Last Update
March 9 2017
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University Hospital Midtown
Atlanta, Georgia, United States, 30308
2
Emory University Winship Cancer Institute
Atlanta, Georgia, United States, 30322
3
Emory Saint Joseph's Hospital
Atlanta, Georgia, United States, 30342